MiniMed Q1 sales rose; UBS lifts price target to $28
MiniMed Group reported Q1 FY2027 net sales of $843M, up 16.6% (15.8% organic). UBS raised its price target to $28 and reiterated a Buy, citing U.S. and international organic growth.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.